Thomas B Casale
Thomas B Casale is an expert in Allergy at University of South Florida (United States). As of October 2026, ScienceLeadR ranks Thomas B Casale in the top 1% of experts worldwide for Hypersensitivity, Rhinitis and Nose Diseases. Thomas B Casale has authored 698 publications, the most recent in 2026, and is an investigator in 20 clinical trials. SLR score: 2,775 (community average: 125). How the SLR is computed.
LeadR Profile
Allergy
Subspecialties: Immunology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Dr Casale is Professor of Medicine and Pediatrics and Chief of Clinical and Translational Research at University of South Florida Division of Allergy and Immunology in Tampa. He is a Past President of the American Academy of Allergy Asthma and Immunology and was Executive Vice President for 10 years. He has served on the board of directors for the American Thoracic Society, The World Allergy Organization, and the American Board of Allergy and Immunology where he was also chair. Dr Casale was also Chief Medical Advisor, Food Allergy Research and Education (FARE) for 4 years. Dr Casale has worked on bench to bedside research with a special focus on biologics and translational research. He has published over 550 scientific papers, reviews, and chapters; organized and directed more than fifty CME programs; and been on planning committees for five World Asthma Meetings. He has been on the editorial boards of multiple journals including JACI and JACI Practice. He is recognized as one of the world’s top 2% most influential scientists by research.com.
Organizations
Career arc: 1987 - 2026
Number : 698
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Steroid Sparing Effect of 300IR House Dust Mite Sublingual Immunotherapy Tablet in Mite Allergic Rhinitis. PMID 42579775 — dust, sublingual immunotherapy, rhinitis, allergic, probability, tablets, immunotherapy, signs and symptoms, rhinitis, therapeutics, steroids | Clin Transl Allergy | 2026 | 0 |
| Route of Allergen Immunotherapy: A Global Look Into Physicians' Motivations. PMID 42410948 — probability, hypersensitivity, prescriptions, allergens, immunotherapy, motivation, physicians, rhinitis, asthma | Allergy | 2026 | 0 |
| The Monoclonals: What have we learned and where are we going? PMID 42119664 — antibodies, hypersensitivity, immunity, antibodies, monoclonal, therapeutics, asthma | Ann Allergy Asthma Immunol | 2026 | 0 |
| Pragmatic Strategies for Reducing Variability and Risk in Food Oral Immunotherapy. PMID 42115504 — hypersensitivity, allergens, immunotherapy, food | Clin Rev Allergy Immunol | 2026 | 0 |
| Pirfenidone and its Derivative: Novel Bronchodilators and Leukocyte Airway Inflammation Inhibitors. PMID 42089319 — bronchodilator agents, lung, bronchoconstrictor agents, myosins, molecular biology, adrenal cortex hormones, neutrophils, airway remodeling, leukocytes, therapeutics, asthma | Am J Respir Cell Mol Biol | 2026 | 0 |
Clinical Studies 20
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
LeadR Networks
Main global connection map